氧化应激
帕金森病
动物研究
多巴胺
认知
脂质过氧化
单胺类神经递质
疾病
神经科学
心理学
去甲肾上腺素
内科学
医学
内分泌学
血清素
受体
作者
Daniel J. Kushigian,Okeanis Vaou
标识
DOI:10.1080/1028415x.2023.2228561
摘要
ABSTRACTABSTRACTObjective: The purpose of this review was to assess the current evidence regarding the associated physiological and cognitive effects of aspartame (APM) consumption and Parkinson's Disease (PD). Methods: A total of 32 studies demonstrating effects of APM on monoamine deficiencies, oxidative stress, and cognitive changes were reviewed. Results: Multiple studies demonstrated decreased brain dopamine, decreased brain norepinephrine, increased oxidative stress, increased lipid peroxidation, and decreased memory function in rodents after APM use. In addition, PD animal models have been found to be more sensitive to the effects of APM. Discussion: Overall, studies of APM use over time yielded more consistent results; however, no study has examined long-term effects on APM in human PD patients. Based on the current evidence, long-term human based observational research is needed to further investigate the potential effect of APM on PD.KEYWORDS: AspartameParkinson's diseasemovement disordersoxidative stressmonoamine neurotransmittersdopaminenorepinephrineserotoninbehaviorlearning & memory Disclosure statementNo potential conflict of interest was reported by the author(s).Data availability statementData sharing is not applicable to this article as no new data were created or analyzed in this study.Additional informationFundingThe author(s) reported there is no funding associated with the work featured in this article.Notes on contributorsDaniel J. KushigianDr. Daniel J. Kushigian is a neurology resident (PGY2) at Umass Chan Medical School. He graduated from Tufts University School of Medicine, earning an M.D. and M.P.H. His interests include movement disorders, medical education, and neuropsychiatry.Okeanis E. VaouDr. Okeanis E. Vaou is the Vice Chair of Faculty Development, division Chief of Movement Disorders and Associate Professor at UT Health at San Antonio. She specializes in treating patients with Parkinson's Disease, Atypical Parkinson's, and other movement disorders. Dr. Vaou is also Board Certified in Sleep Medicine with a focus on treating sleep disorders associated with movement disorders. Her interests include deep brain stimulation, medical education, and sleep disorders in Parkinson's Disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI